Skip to main content
. Author manuscript; available in PMC: 2012 Mar 1.
Published in final edited form as: Arterioscler Thromb Vasc Biol. 2010 Dec 16;31(3):598–607. doi: 10.1161/ATVBAHA.110.216184

Figure 2.

Figure 2

Growth and EMT. A, Increase in MVEC-4 (○), MVEC-5 (■), and MVIC-7 (▲) cell number over 7 days. B, MVEC-5 treated with TGF-β1 (2 ng/mL), VEGF-A (10 ng/mL), or both for 5 days and analyzed by Western blot for α-SMA and CD31. β-Tubulin served as a loading control.